{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:53:14Z","timestamp":1793134394193,"version":"4.5.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Best Friends Animal Society"},{"name":"SOCK-FIP at the Center for Companion Animal Health at UC Davis"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Feline Medicine and Surgery"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Feline infectious peritonitis (FIP) is a fatal disease caused by feline coronavirus. The nucleoside analog GS-441524, the parent nucleoside of remdesivir, is the most commonly used FIP antiviral. Remdesivir is Food and Drug Administration approved to treat COVID-19 in humans and has been used primarily as an adjunctive treatment for FIP. Data on its efficacy as a first-line oral therapy, as well as its use to treat non-effusive FIP, remain limited. Therefore, this study compares the effectiveness of oral remdesivir vs GS-441524 as a first-line antiviral therapy for cats with non-effusive FIP in a prospective, randomized, double-blind, non-inferiority clinical trial. Furthermore, this study aims to bolster the literature supporting remdesivir use in these cats, anticipating potential future fluctuations in drug cost, availability and legal access.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cats with non-effusive FIP were randomly assigned to receive either oral remdesivir (38\u201342\u2009mg\/kg, n\u2009=\u200910) or oral GS-441524 (18\u201322\u2009mg\/kg, n\u2009=\u200910) q24h for 84 days (12 weeks). Follow-up was conducted at 6 and 16 weeks, and response to therapy, survival and disease-free remission were assessed. Long-term follow-up was also obtained by contacting owners 1.5\u20132 years after conclusion of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At week 16, 9\/10 (90%) cats treated with remdesivir and 7\/10 (70%) cats treated with GS-441524 were alive and in clinical remission. Remdesivir met the statistical criteria for non-inferiority, with a difference in disease-free survival of 20% (90% confidence interval \u20138.5 to +48.5). All deaths during treatment occurred within the first 11 days of the trial. Long-term follow-up revealed new onset of clinical signs and raised concerns for potential late relapse of disease in four cats (two in each group).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and relevance<\/jats:title>\n                    <jats:p>This study supports the hypothesis that oral remdesivir is non-inferior to GS-441524 for achieving survival and disease-free remission from FIP at 16 weeks. Given evolving global drug access and costs, remdesivir is a viable first-line option.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1098612x261433057","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:03:45Z","timestamp":1773227025000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of non-effusive feline infectious peritonitis using oral remdesivir or GS-441524: a randomized, double-blind, non-inferiority trial"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4825-4881","authenticated-orcid":false,"given":"Terza","family":"Brostoff","sequence":"first","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California at Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jully","family":"Pires","sequence":"additional","affiliation":[{"name":"Veterinary Center for Clinical Trials, School of Veterinary Medicine, University of California at Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Rose","sequence":"additional","affiliation":[{"name":"Veterinary Center for Clinical Trials, School of Veterinary Medicine, University of California at Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Cohen-Davidyan","sequence":"additional","affiliation":[{"name":"Veterinary Center for Clinical Trials, School of Veterinary Medicine, University of California at Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Castillo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California at Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0057-0604","authenticated-orcid":false,"given":"Brian G","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California at Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle L","family":"Reagan","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2018.04.026"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.1997.210.09.1313"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2014.04.016"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X19825701"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15081680"},{"key":"e_1_3_3_7_2","article-title":"Unlicensed GS-441524-like antiviral therapy can be effective for at-home treatment of feline infectious peritonitis.","volume":"11","author":"Jones S","year":"2021","unstructured":"Jones S, Novicoff W, Nadeau J, et al. Unlicensed GS-441524-like antiviral therapy can be effective for at-home treatment of feline infectious peritonitis. Animals (Basel) 2021; 11. DOI: 10.3390\/ani11082257.","journal-title":"Animals (Basel)"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11101209"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.16832"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1422408"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.16804"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.16803"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.17187"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsap.13869"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/avj.13433"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X251335189"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/v16071144"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14050507"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X231183250"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.15780"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X231194460"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14070717"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X221118761"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84754-0"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300985817728557"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsap.13849"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01929"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00162-20"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07750-4"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13112228"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1513-8"},{"key":"e_1_3_3_34_2","unstructured":"Sealed Envelope. Power calculator for binary outcome non-inferiority trial. https:\/\/www.sealedenvelope.com\/power\/binary-noninferior\/ (2012 accessed 16 December 2024)."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.68.7.694"},{"key":"e_1_3_3_36_2","unstructured":"Bobbitt Z. Confidence interval for the difference in proportions calculator. Statology. https:\/\/www.statology.org\/confidence-interval-difference-in-proportions-calculator\/ (2020 accessed 4 August 2025)."},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/v16030462"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szaf025"}],"container-title":["Journal of Feline Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1098612X261433057","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1098612X261433057","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1098612X261433057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:40:57Z","timestamp":1784086857000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1098612X261433057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1177\/1098612X261433057"],"URL":"https:\/\/doi.org\/10.1177\/1098612x261433057","relation":{},"ISSN":["1098-612X","1532-2750"],"issn-type":[{"value":"1098-612X","type":"print"},{"value":"1532-2750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1098612X261433057"}}